Other Species / Isoforms
  EAP1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsAAQVsss
0 1
EAP1 (human) ______MsAAQVsss S2-p
EAP1 (mouse) ______MSAAQVSSS S2
EAP1 (rat) ______MSAAQVSSS S2
S7-p
_MsAAQVsssRRQsC
0 1
EAP1 (human) _MsAAQVsssRRQsC S7-p
EAP1 (mouse) _MSAAQVSSSRRQsC S7
EAP1 (rat) _MSAAQVSSSRRQSC S7
S8-p
MsAAQVsssRRQsCY
0 1
EAP1 (human) MsAAQVsssRRQsCY S8-p
EAP1 (mouse) MSAAQVSSSRRQsCY S8
EAP1 (rat) MSAAQVSSSRRQSCY S8
S9-p
sAAQVsssRRQsCYL
0 1
EAP1 (human) sAAQVsssRRQsCYL S9-p
EAP1 (mouse) SAAQVSSSRRQsCYL S9
EAP1 (rat) SAAQVSSSRRQSCYL S9
S13-p
VsssRRQsCYLCDLP
0 7
EAP1 (human) VsssRRQsCYLCDLP S13-p
EAP1 (mouse) VSSSRRQsCYLCDLP S13-p
EAP1 (rat) VSSSRRQSCYLCDLP S13
S69-p
GCFQDGRsPGPPPPV
Upstream
0 26
Treatment
  • ischemia
EAP1 (human) GCFQDGRsPGPPPPV S69-p
EAP1 (mouse) GCFQDGRsPGPPPPV S69-p
EAP1 (rat) GCFQDGRsPGPPPPV S69-p
K79-ub
PPPPVGVkTVALSAK
0 3
EAP1 (human) PPPPVGVkTVALSAK K79-ub
EAP1 (mouse) PPPPVGVkTVALSAK K79-ub
EAP1 (rat) PPPPVGVKTVALSAK K79
D132-ca
QQQLNHVdGSsKPAV
0 1
EAP1 (human) QQQLNHVdGSsKPAV D132-ca
EAP1 (mouse) QQQLNHVDGSTKPAV D113
EAP1 (rat) PQQLNHVDGSTKPAV D120
S135-p
LNHVdGSsKPAVLAA
0 1
EAP1 (human) LNHVdGSsKPAVLAA S135-p
EAP1 (mouse) LNHVDGSTKPAVLAA T116
EAP1 (rat) LNHVDGSTKPAVLPA T123
S152-p
GLERYGLsAAAAAAA
0 1
EAP1 (human) GLERYGLsAAAAAAA S152-p
EAP1 (mouse) GLERYGLSAAAAAAA S133
EAP1 (rat) GLERYGLSAAAAAAA S140
R170-m1
AAVEQRSrFEYPPPP
0 2
EAP1 (human) AAVEQRSrFEYPPPP R170-m1
EAP1 (mouse) AAVEQRSRFEYPPPP R150
EAP1 (rat) AAVEQRSRFEYPPPP R158
S179
EYPPPPVSLGSSSHT
0 2
EAP1 (human) EYPPPPVSLGSSSHT S179
EAP1 (mouse) EYPPPPVsLGSSSHA S159-gl
EAP1 (rat) EYPPPPVSLGSSSHA S167
S215-p
PPELNRQsPNssSAA
Upstream
0 37
Treatment
  • SII_angiotensin_2
EAP1 (human) PPELNRQsPNssSAA S215-p
EAP1 (mouse) PPELNRQsPNSsSAA S195-p
EAP1 (rat) PPELNRQsPNSSSAA S203-p
S218-p
LNRQsPNssSAAAsV
0 1
EAP1 (human) LNRQsPNssSAAAsV S218-p
EAP1 (mouse) LNRQsPNSsSAATSV S198
EAP1 (rat) LNRQsPNSSSAATSV S206
S219-p
NRQsPNssSAAAsVA
0 2
EAP1 (human) NRQsPNssSAAAsVA S219-p
EAP1 (mouse) NRQsPNSsSAATSVA S199-p
EAP1 (rat) NRQsPNSSSAATSVA S207
S224-p
NssSAAAsVAsRRGT
0 2
EAP1 (human) NssSAAAsVAsRRGT S224-p
EAP1 (mouse) NSsSAATSVAsRRGT S204
EAP1 (rat) NSSSAATSVASRRGT S212
S227-p
SAAAsVAsRRGTHGG
0 4
EAP1 (human) SAAAsVAsRRGTHGG S227-p
EAP1 (mouse) SAATSVAsRRGTHSG S207-p
EAP1 (rat) SAATSVASRRGTHSG S215
T286-p
LGSRGPPtPAPPGAP
0 1
EAP1 (human) LGSRGPPtPAPPGAP T286-p
EAP1 (mouse) GGSRGPPTPAPPGAP T265
EAP1 (rat) GGSRGPPTPAPPGAP T273
S334-p
AGGKRPGsVsstDQE
Upstream
0 35
Treatment
  • EGF
  • SB202190
  • U0126
EAP1 (human) AGGKRPGsVsstDQE S334-p
EAP1 (mouse) AAGKRPGsVSsTDQE S313-p
EAP1 (rat) AAGKRPGsVSSTDQE S321-p
S336-p
GKRPGsVsstDQERE
0 1
EAP1 (human) GKRPGsVsstDQERE S336-p
EAP1 (mouse) GKRPGsVSsTDQERE S315
EAP1 (rat) GKRPGsVSSTDQERE S323
S337-p
KRPGsVsstDQEREL
0 3
EAP1 (human) KRPGsVsstDQEREL S337-p
EAP1 (mouse) KRPGsVSsTDQEREL S316-p
EAP1 (rat) KRPGsVSSTDQEREL S324
T338-p
RPGsVsstDQERELK
0 1
EAP1 (human) RPGsVsstDQERELK T338-p
EAP1 (mouse) RPGsVSsTDQERELK T317
EAP1 (rat) RPGsVSSTDQERELK T325
K371-ub
RAEEWASkPkMVRDT
0 1
EAP1 (human) RAEEWASkPkMVRDT K371-ub
EAP1 (mouse) RAEEWANKPKMVRDT K350
EAP1 (rat) RAEEWANKPKMVRDT K358
K373-ub
EEWASkPkMVRDTLL
0 1
EAP1 (human) EEWASkPkMVRDTLL K373-ub
EAP1 (mouse) EEWANKPKMVRDTLL K352
EAP1 (rat) EEWANKPKMVRDTLL K360
Y388-p
TLAGCTPyEVRFKKD
0 1
EAP1 (human) TLAGCTPyEVRFKKD Y388-p
EAP1 (mouse) TLAGCTPYEVRFKKD Y367
EAP1 (rat) TLAGCTPYEVRFKKD Y375
S397-p
VRFKKDHsLLGRVFA
0 3
EAP1 (human) VRFKKDHsLLGRVFA S397-p
EAP1 (mouse) VRFKKDHsLLGRVFA S376-p
EAP1 (rat) VRFKKDHSLLGRVFA S384
K410-ub
FAFDAVSkPGMDYEL
0 1
EAP1 (human) FAFDAVSkPGMDYEL K410-ub
EAP1 (mouse) FAFDAVSKPGMDYEL K389
EAP1 (rat) FAFDAVSKPGMDYEL K397
Y423
ELKLFIEYPTGSGNV
0 1
EAP1 (human) ELKLFIEYPTGSGNV Y423
EAP1 (mouse) ELKLFIEyPTGSGNV Y402-p
EAP1 (rat) ELKLFIEYPTGSGNV Y410
S432
TGSGNVYSSASGVAK
0 1
EAP1 (human) TGSGNVYSSASGVAK S432
EAP1 (mouse) TGSGNVYssASGVAK S411-p
EAP1 (rat) TGSGNVYSSASGVAK S419
S433
GSGNVYSSASGVAKQ
0 1
EAP1 (human) GSGNVYSSASGVAKQ S433
EAP1 (mouse) GSGNVYssASGVAKQ S412-p
EAP1 (rat) GSGNVYSSASGVAKQ S420
K458-ac
RGLSSGFkYLEYEkK
0 1
EAP1 (human) RGLSSGFkYLEYEkK K458-ac
EAP1 (mouse) RGLSSGFKYLEYEKK K437
EAP1 (rat) RGLSSGFKYLEYEKK K445
K458-ub
RGLSSGFkYLEYEkK
0 2
EAP1 (human) RGLSSGFkYLEYEkK K458-ub
EAP1 (mouse) RGLSSGFkYLEYEKK K437-ub
EAP1 (rat) RGLSSGFKYLEYEKK K445
K458-sm
RGLSSGFkYLEYEkK
0 1
EAP1 (human) RGLSSGFkYLEYEkK K458-sm
EAP1 (mouse) RGLSSGFKYLEYEKK K437
EAP1 (rat) RGLSSGFKYLEYEKK K445
K464-ub
FkYLEYEkKHGSGDW
0 1
EAP1 (human) FkYLEYEkKHGSGDW K464-ub
EAP1 (mouse) FkYLEYEKKHGSGDW K443
EAP1 (rat) FKYLEYEKKHGSGDW K451
S519-p
VSLSRAPsAPPGtGA
0 26
EAP1 (human) VSLSRAPsAPPGtGA S519-p
EAP1 (mouse) VSLSRAPsAPPGTGA S498-p
EAP1 (rat) VSLSRAPSAPPGTGA S506
T524-p
APsAPPGtGALPPAA
0 1
EAP1 (human) APsAPPGtGALPPAA T524-p
EAP1 (mouse) APsAPPGTGALPPAA T503
EAP1 (rat) APSAPPGTGALPPAA T511
S540-p
SGRGAAAsLRKRKAs
0 2
EAP1 (human) SGRGAAAsLRKRKAs S540-p
EAP1 (mouse) TGRGAASSLRKRKAs S519
EAP1 (rat) TGRGAAASLRKRKAs S527
S547-p
sLRKRKAsPEPPDsA
Upstream
0 83
Treatment
  • LRRK2-IN-1
  • metastatic potential
EAP1 (human) sLRKRKAsPEPPDsA S547-p
EAP1 (mouse) SLRKRKAsPEPPDsA S526-p
EAP1 (rat) SLRKRKAsPEPPDSA S534-p
S553-p
AsPEPPDsAEGALKL
0 7
EAP1 (human) AsPEPPDsAEGALKL S553-p
EAP1 (mouse) AsPEPPDsAESALKL S532-p
EAP1 (rat) AsPEPPDSAESALKL S540
T610-p
LGPHSNRttPPESAP
0 3
EAP1 (human) LGPHSNRttPPESAP T610-p
EAP1 (mouse) LGPHSNRttPPESAP T589-p
EAP1 (rat) LGPHSNRtTPPESAP T597-p
T611-p
GPHSNRttPPESAPQ
0 2
EAP1 (human) GPHSNRttPPESAPQ T611-p
EAP1 (mouse) GPHSNRttPPESAPQ T590-p
EAP1 (rat) GPHSNRtTPPESAPQ T598
S622-p
SAPQNGPsPMAALMS
0 4
EAP1 (human) SAPQNGPsPMAALMS S622-p
EAP1 (mouse) SAPQNGPsPMAALMS S601-p
EAP1 (rat) SAPQNGPSPMAALMS S609
T633
ALMSVADTLGTAHsP
0 1
EAP1 (human) ALMSVADTLGTAHsP T633
EAP1 (mouse) ALMSVADtLGtAHsP T612-p
EAP1 (rat) ALMSVADTLGTAHsP T620
T636
SVADTLGTAHsPKDG
0 1
EAP1 (human) SVADTLGTAHsPKDG T636
EAP1 (mouse) SVADtLGtAHsPKDG T615-p
EAP1 (rat) SVADTLGTAHsPKDG T623
S639-p
DTLGTAHsPKDGSSV
0 16
EAP1 (human) DTLGTAHsPKDGSSV S639-p
EAP1 (mouse) DtLGtAHsPKDGSSV S618-p
EAP1 (rat) DTLGTAHsPKDGSSV S626-p
S657-p
TASARRNsssPVsPA
Upstream
0 92
Treatment
  • EGF
  • SB202190
EAP1 (human) TASARRNsssPVsPA S657-p
EAP1 (mouse) TASARRNsssPVsPA S636-p
EAP1 (rat) TASARRNsssPVsPA S644-p
S658-p
ASARRNsssPVsPAs
Upstream
0 39
Treatment
  • EGF
  • nocodazole
EAP1 (human) ASARRNsssPVsPAs S658-p
EAP1 (mouse) ASARRNsssPVsPAs S637-p
EAP1 (rat) ASARRNsssPVsPAS S645-p
S659-p
SARRNsssPVsPAsV
Upstream
0 104
Treatment
  • ischemia
  • nocodazole
EAP1 (human) SARRNsssPVsPAsV S659-p
EAP1 (mouse) SARRNsssPVsPAsV S638-p
EAP1 (rat) SARRNsssPVsPASV S646-p
S662-p
RNsssPVsPAsVPGQ
Upstream
0 112
Regulatory protein:
  • TBK1 (human)
Treatment
  • EGF
  • ischemia
  • SB202190
EAP1 (human) RNsssPVsPAsVPGQ S662-p
EAP1 (mouse) RNsssPVsPAsVPGQ S641-p
EAP1 (rat) RNsssPVsPASVPGQ S649-p
S665-p
ssPVsPAsVPGQRRL
0 15
EAP1 (human) ssPVsPAsVPGQRRL S665-p
EAP1 (mouse) ssPVsPAsVPGQRRL S644-p
EAP1 (rat) ssPVsPASVPGQRRL S652
S705-p
HPQNIPDsPMANSGP
0 1
EAP1 (human) HPQNIPDsPMANSGP S705-p
EAP1 (mouse) HPQNIPDSPMANSGP S684
EAP1 (rat) HPQNIPDSPMANSGP S692
K748-ub
PCSRESIkAQGATGE
0 3
EAP1 (human) PCSRESIkAQGATGE K748-ub
EAP1 (mouse) PCSRESIkAQGATGE K727-ub
EAP1 (rat) PCSRESIKAQGATGE K735